Reducing High Risk Primary Tumor Clinical Target Volumes (CTVp1) in Non-metastatic Nasopharyngeal Carcinoma

Abroad (travel likely)Recruiting

Conditions

Nasopharyngeal Carcinoma · Intensity-Modulated Radiotherapy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Zhongshan City People's Hospital, Zhongshan, Guangdong, China
Contact: Study coordinator (Guiqiong Xu) · donna_shee@163.com · +8613528109888
Contact: Study coordinator (Yu-long Xie, MD) · xieyl1@sysucc.org.cn · +8615625031643

Study leads

Gui-qiong Xu
Principal Investigator
Zhongshan People's Hospital, Guangdong, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Nasopharyngeal Carcinoma · Immune Checkpoint Inhibitor · Radiotherapy

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China · Nanning, China

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Metastatic Nasopharyngeal Carcinoma · Recurrent Nasopharyngeal Carcinoma · Stage IV Nasopharyngeal Carcinoma AJCC v8

Abroad (travel likely)RecruitingPHASE2

Dublin, United States · Fremont, United States

Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC)

Nasopharyngeal Carcinoma

Abroad (travel likely)RecruitingPHASE2

Palo Alto, United States

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma · Stage III Nasopharyngeal Carcinoma AJCC v8 · Stage IVA Nasopharyngeal Carcinoma AJCC v8

Abroad (travel likely)Recruiting

San Francisco, United States